Experimental RNA Treatment Shows Promise Against Genetic Brain Disorder in Animal Study
Researchers at Johns Hopkins University School of Medicine and Academia Sinica developed an experimental RNA-based treatment that prevented brain damage and improved learning and memory in mice with a rare genetic mutation.
🏥Public HealthPhoto: Medical Xpress
Key points
- Researchers at Johns Hopkins and Academia Sinica tested an ASO treatment on mice with a rare GRIA1 gene mutation.
- The mutation disrupts AMPA receptors, allowing harmful calcium levels to damage the hippocampus and impair social and learning behaviors.
- A single early-life dose of the RNA therapy suppressed the mutant gene, preventing neuronal degeneration and improving behavioral outcomes.
Investigators at Johns Hopkins University School of Medicine and Academia Sinica in Taiwan have formulated an experimental RNA-based intervention that successfully prevents brain damage and enhances learning, memory, and social behavior in mice harboring a rare genetic mutation linked to autism spectrum disorder and intellectual disability. The team investigated an alteration known as the A636T mutation within the GluA1 subunit of AMPA receptors, which are vital for neuronal communication and neural circuit formation.
Normal developmental processes in these receptors typically restrict calcium influx to protect neurons, but the mutation allows excessive calcium entry, triggering hippocampal damage, neuroinflammation, and behavioral impairments in genetically engineered mice. To counteract this, the team created a synthetic antisense oligonucleotide (ASO) to selectively silence the aberrant RNA message from the mutant GRIA1 gene copy while leaving the healthy copy intact. A single administration of this optimized molecule shortly after birth halted neuronal damage, restored synaptic function, and significantly ameliorated learning and behavioral deficits in the subjects.
While this preclinical study offers an encouraging proof of concept for precision RNA therapeutics, experts emphasize that findings from animal models require extensive further research, including clinical trials, before determining safety and efficacy in humans. Readers considering personal medical choices related to neurodevelopmental conditions should consult a qualified physician. What to know: Researchers successfully used an ASO therapy to selectively silence a mutated gene tied to neurodevelopmental issues in mice, paving the way for future exploration of personalized genetic treatments.
"Our findings show how a single genetic mutation can disrupt brain development and lead to significant neurological impairments," stated Richard L. Huganir, co-corresponding author from the Johns Hopkins University School of Medicine.
Source Medical Xpress — medicalxpress.com/news/2026-11-precision-rna-therapy-brain-receptor.html ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.